DOJ lauds Guardant Health’s cooperation in cancer test false claims case
By 
Jeff Dale2024-07-17T20:37:00
California-based cancer testing company Guardant Health agreed to pay more than $945,000 to settle allegations levied by the Department of Justice (DOJ) of violating the False Claims Act and Stark Law.
Guardant will pay nearly $914,000 to settle allegations of the violating the False Claims Act, including more than $600,000 in restitution, according to the company’s settlement agreement. Additionally, the company will pay more than $31,000 in an administrative settlement with the Defense Health Agency, the DOJ announced in a press release Tuesday.
The DOJ acknowledged the company’s voluntary self-disclosure to the Department of Health and Human Services’ Office of the Inspector General, among other remedial measures promptly undertaken in reaching settlement.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
News BriefAvantor agrees to pay $5.3M to settle false claims, chemicals reporting violations
Laboratory supply company Avantor agreed to pay $5.3 million to settle allegations, first brought by a whistleblower, that it overcharged four federal agencies and failed to comply with chemical regulations, the Department of Justice said.
-
News BriefKindred hospice agrees to pay $19M in multi-state DOJ false claims case
A multi-state hospice home health provider agreed to pay $19.4 million to settle allegations that it paid kickbacks and knowingly billed federal health programs to treat non-terminally ill patients.
-
ArticleGeopolitical risks and global threats drive emerging national security compliance teams
Geopolitical uncertainty is becoming the defining feature of the decade, and global powers are increasingly using geo-economic power to promote national interest and defend their critical interests. Multinational companies, consultants, and global law firms are responding by setting up dedicated national security teams.
More from Regulatory Enforcement
-
ArticleCMA holds companies responsible for false claims, fake reviews ‘throughout supply chain’
Companies face large fines if they spread false marketing claims or fake reviews about their products and services—as well as those by suppliers—under a toughened competition regime in the U.K. aimed at enhancing consumer protection.
-
ArticleFTC warns VISA and other processors that company policies may lead to debanking
Visa, Mastercard, PayPal, and Stripe have received letters from the Federal Trade Commission, warning the companies to end any policies or terms of service that may result in the “debanking” of customers.
-
ArticleDOJ makes good on corporate-friendly enforcement policy with Balt resolution
The ink was barely dry on the U.S. Department of Justice’s new corporate enforcement policy (CEP) when the agency announced it would not prosecute Balt SAS for alleged bribery violations.